“…Recently, a plethora of comparative studies have identified intriguing associations between the composition of the microbiome and numerous diseases including various metabolic disorders (Greenblum et al, 2012; Karlsson et al, 2014; Qin et al, 2013), malignancies (Schulz et al, 2014), autoimmune diseases (Scher et al, 2013), and neurological developmental disorders (Hsiao et al, 2013). Such studies can take two different approaches to profile the composition of the microbiome (Noecker et al, 2016). The first approach focuses on taxonomy, aiming to profile the abundances of different microbial clades in each sample, either by targeted sequencing of the ribosomal 16S gene and operational taxonomic units clustering (Caporaso et al, 2010; Schloss et al, 2009) or by shotgun metagenomic sequencing and quantification of clade-specific marker genes’ abundances (Segata et al, 2012).…”